Biovica International AB (OSTO:BIOVIC B) 3-Year Revenue Growth Rate : 13.00% (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB 3-Year Revenue Growth Rate?

Biovica International AB's Revenue per Share for the three months ended in Jan. 2024 was kr0.02.

During the past 12 months, Biovica International AB's average Revenue per Share Growth Rate was 20.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 13.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was -12.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 9 years, the highest 3-Year average Revenue per Share Growth Rate of Biovica International AB was 79.40% per year. The lowest was -24.00% per year. And the median was 9.35% per year.

Competitive Comparison of Biovica International AB's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Biovica International AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biovica International AB's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Biovica International AB's 3-Year Revenue Growth Rate falls into.

Biovica International AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Biovica International AB (OSTO:BIOVIC B) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Biovica International AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Biovica International AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Biovica International AB (OSTO:BIOVIC B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

9II:Germany

Address

Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37

Website

http://www.biovica.com

Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines